Brings cutting edge surgery and precise tumor operation platform to
WINNIPEG, Feb. 7, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced that neurosurgeons at the
First Affiliated Hospital of Zhengzhou University in Zhengzhou City,
China, have successfully performed the first case involving an adult
male brain tumor patient using the recently installed VISIUS® Surgical Theatre.
Allowing for multiple MR scanning during brain tumor operations without
compromising patient safety, the VISIUS Surgical Theatre features a
high-field MR scanner that travels on demand using ceiling-mounted
rails into a state-of-the-art neurosurgical operating room. As in this
initial case, serial scanning gives the surgeon the ability to assess
and perform further resection to remove as much tumor as possible.
With integrated technologies and control systems for imaging,
patient-handling and information management, the VISIUS Surgical
Theatre provides unmatched intraoperative vision to surgeons to assist
in their surgical decision-making and enhance treatment precision. When
not needed for intraoperative imaging, the scanner remains in a
diagnostic room where it can be used for inpatient and outpatient
Zhengzhou University Hospital is the third IMRIS system installed in
China. Other locations are: PLA General Hospital in Beijing and Huashan
Hospital at Fudan University in Shanghai. Two other VISIUS Surgical
Theatres are currently being installed at Peking Union Medical College
Hospital in Beijing and First Affiliated Hospital of Jilin University
The day before the first procedure, Dr. Xianzhi Liu, chief neurosurgeon,
reviewed the surgical suite with province health department
representatives. "Since we are the biggest and leading hospital in
Henan province," he said, "we have a responsibility to our patients to
utilize cutting edge technology that brings the most precise surgical
When the hospital announced purchase of the VISIUS Surgical Theatre in
March 2012, Kan Quancheng, hospital president, said the suite "is the
essential, leading-edge technology that will take us to the next level
of research and clinical practice, especially in neurosurgery."
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. VISIUS Surgical Theatres
serve the neurosurgical, cardiovascular and cerebrovascular markets and
have been selected by leading medical institutions around the world.
SOURCE IMRIS Inc.